Johnson & Johnson : First Quarter 2024 2024 First-Quarter Earnings Transcript
REFINITIV STREETEVENTS EDITED TRANSCRIPT Q1 2024 Johnson & Johnson Earnings Call EVENT...
Source: marketscreener.com
📰 Tim Schmid News
Tim Schmid News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Schmid. Real-time updates on events, politics, business and more.
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
Johnson & Johnson will participate in the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15th, at the InterContinental Barclay Hotel, New York. Tim Schmid, Executive Vice...
New York United States Tim Schmid Intercontinental Barclay Hotel Markets Global Healthcare Conference Executive Vice President
Source: marketscreener.com
Johnson & Johnson to acquire Shockwave Medical for $13.1B
Johnson & Johnson (NYSE: JNJ) announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion.
Source: massdevice.com
Johnson & Johnson to Acquire Shockwave Medical
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...
Source: marketscreener.com
Biggest stories from the 2024 J.P. Morgan Healthcare Conference
Some of the biggest names in the medtech space came together this week at the J.P. Morgan Healthcare Conference.
Source: massdevice.com
Ashley McEvoy takes board role at consumer goods giant
Less than two months after leaving Johnson & Johnson MedTech, Ashley McEvoy has taken on a role on the board of Procter & Gamble.
Source: massdevice.com
The biggest medtech personnel moves of 2023
The leadership change at Johnson & Johnson MedTech will go down as the year's biggest personnel move in medtech, barring a December surprise.
Source: massdevice.com
Johnson & Johnson MedTech says new products will fuel growth
Johnson & Johnson (NYSE: JNJ) today set expectations on growth for its Innovative Medicine and MedTech pipelines.
Source: massdevice.com
Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure - Johnson & Johnson (NYSE:JNJ)
The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit, potentially altering the anticipated succession plans within the healthcare giant
Source: benzinga.com
Johnson & Johnson to Host Enterprise Business Review
Johnson & Johnson will hold an Enterprise Business Review for the investment community on Tuesday, December 5, 2023. During the event, Company leaders will share a detailed review of the Innovative...
Source: marketscreener.com